The Transgenic and Gene Targeting Institutional Facility at the University of Kansas Medical Center is an institutional research support facility providing a centralized service for the production of novel transgenic and gene targeted rodents and pluripotent stem cells for the investigators of KUMC and the surrounding Kansas City research community. Our core uses cutting edge technologies, including CRISPR/Cas9 genome editing, for the generation of these models.